We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Says No to Using Split Predicates in ‘Substantial Equivalence’ Applications
U.S. FDA Says No to Using Split Predicates in ‘Substantial Equivalence’ Applications
Manufacturers are all but blocked from using split predicates for 510(k) devices, under a newly finalized U.S. Food and Drug Administration guidance on substantial equivalence determinations.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor